ARALAST NP

Indicated For

Alpha-1 antitrypsin deficiency, emphysema

About This Medication

# Takeda Patient Support Co-Pay Assistance Program Patient Guide: How to Get ARALAST NP at Low or No Cost ARALAST NP (Alpha-1 Proteinase Inhibitor (Human)) is a prescription infusion therapy designed to treat adults with emphysema due to severe alpha-1 antitrypsin deficiency (AATD), a genetic condition where the body lacks enough of a protective protein called alpha-1 antitrypsin, leading to lung damage over time. The **Takeda Patient Support Co-Pay Assistance Program** helps eligible, commercially insured patients reduce or eliminate out-of-pocket costs for this vital medication, potentially covering up to 100% of co-pays, making treatment more accessible. ## Who Qualifies for the Program? This program is specifically for patients prescribed **ARALAST NP** who meet strict eligibility criteria. You must: - Have a prescription for ARALAST NP for an FDA-approved use, such as emphysema from congenital alpha-1 antitrypsin deficiency (AATD).[5][8] - Be **commercially insured** (including Marketplace plans). This excludes government programs like Medicare, Medicare Advantage, Medicaid, TRICARE, VA benefits, state pharmaceutical assistance, or Medicare Part D.[5][9] - Not have insurance that fully covers the medication's cost. The program does not have specified income thresholds, focusing instead on insurance type and commercial coverage. It's not a needs-based free drug program like Takeda's separate Help at Hand (which is for uninsured or underinsured patients and may not cover ARALAST NP).[3][7] ## About ARALAST NP **ARALAST NP** is an intravenous infusion derived from human plasma, containing alpha-1 proteinase inhibitor to raise protective protein levels in your blood and lungs. This helps prevent enzymes from breaking down lung tissue (alveoli), slowing emphysema progression in AATD patients.[8] Administered weekly by a healthcare provider (typically 60 mg/kg body weight), it's given in a doctor's office, infusion center, or at home with nursing support. Common side effects include dizziness, headache, nausea, fever, or itching at the infusion site. Rarely, allergic reactions or transmission of infectious agents can occur—discuss risks with your doctor. Before starting, inform your provider of allergies (especially to IgA), liver issues, COPD, pregnancy, or breastfeeding.[8] ARALAST NP, made by Baxalta Inc. (a Takeda subsidiary), was FDA-approved in 2002 and remains a key therapy for severe AATD.[8] ## Income Eligibility Breakdown No specific income limits are listed; eligibility hinges on commercial insurance. However, program benefits have annual maximums (check www.takedapatientsupport.com/copay for your product's cap). Co-pay maximizer plans may reduce assistance—notify the program if enrolled.[9] | Eligibility Factor | Details | Eligible? | |-------------------|---------|-----------| | **Commercial Insurance** | Marketplace or private plans | **Yes** [5][9] | | **Medicare/Medicaid** | Any federal/state government plan | **No** [5] | | **Income Level** | No thresholds specified | **N/A** | | **FDA-Approved Use** | Emphysema from AATD | **Yes** [5][8] | | **Full Insurance Coverage** | If co-pay is $0 | **No** | ## Insurance Requirements **Commercial insurance only**—no government plans. Your plan must require some out-of-pocket payment for ARALAST NP. Takeda monitors for 'co-pay maximizer' programs that manipulate assistance to minimize insurer payouts; enrollment in these may lead to reduced or discontinued aid. Call 1-866-888-0660 if your plan changes.[9] Specialty pharmacy coordination is included.[5] ## Step-by-Step Application Process 1. **Consult Your Doctor**: Confirm ARALAST NP is right for you and have them complete the Start Form (available at aralastnp.com/hcp/start-form).[2][5] 2. **Sign Authorization**: Review and sign the patient section of the form, consenting to eligibility review and contact.[5] 3. **Submit the Form**: Your doctor submits electronically or via phone. Multiple methods available (phone: 844-755-5751 or 1-866-888-0660, M-F 8:30AM-8PM ET).[1][2] 4. **Eligibility Review**: Takeda Patient Support reviews within days (exact time not specified).[2] 5. **Get Contacted**: A dedicated specialist calls to confirm enrollment, explain benefits, and coordinate with your pharmacy or site of care.[5] 6. **Receive Medication**: Once approved, ARALAST NP ships to your doctor's office or home. Support includes insurance navigation, nursing tips, and multilingual assistance.[5] ## Timeline and Delivery Processing time isn't specified but starts promptly after form submission—Takeda confirms eligibility quickly.[2] Your specialist handles specialty pharmacy logistics. Medication ships free to physician office or patient home. **Reauthorization is required** periodically; your doctor resubmits forms, and your specialist reminds you.[9] ## Alternatives if Denied or Ineligible - **Government Insurance**: Explore state programs or patient access networks (not through Takeda co-pay). - **Uninsured/Underinsured**: Takeda's Help at Hand may provide free meds if eligible (check takeda.com).[3][7] - **Other Assistance**: Independent foundations like PAN Foundation or Patient Access Network; compare biosimilars (none specified for ARALAST NP). - **Appeal**: Contact your specialist at 1-866-888-0660 to discuss denial reasons and options.[1] Contact Takeda immediately for plan changes. ## Important Disclaimer This guide is for informational purposes only and not a substitute for medical or financial advice. Eligibility, terms, and benefits can change; annual caps apply (see takedapatientsupport.com/copay). Program excludes certain plans and may end anytime. Consult your doctor and review full terms at enrollment. Takeda reserves rights to amend or terminate.[5][9] (Word count: 942)

Program information last verified: March 30, 2026